Cardiovascular Support (Off-label): Adjunctive therapy in certain cardiomyopathies where fatty acid metabolism is impaired
DISCUSSION This systematic review and meta-analysis indicated that L-carnitine supplementation significantly reduces blood levels of TC and TG in patients with liver disease, but is not effective in reducing levels of HDL or LDL
Its research profile makes it especially relevant for studies focused on metabolic flexibility, mitochondrial energy output, exercise-related signaling, cardiometabolic models, fatty acid utilization, and cellular energy demand
On top of these benefits, Lipo-C injections are extremely safe and low risk
Regular monitoring of metabolic markers, kidney function, and overall health is advisable